F. Boissiere et al., CHOLINE-ACETYLTRANSFERASE MESSENGER-RNA EXPRESSION IN THE STRIATAL NEURONS OF PATIENTS WITH ALZHEIMERS-DISEASE, Neuroscience letters, 225(3), 1997, pp. 169-172
Besides cortical pathology, Alzheimer's disease (AD) is associated wit
h a massive loss of cholinergic neurons in the basal forebrain. The re
sulting cortical cholinergic depletion is thought to contribute to the
major cognitive impairment described in AD. A selective loss of choli
nergic neurons has also been observed in the ventral striatum, despite
the lack of any major neurochemical dysfunction in the striatum of pa
tients with AD. To examine possible changes in the functional activity
of the neurons that remain in the striatum of AD patients, the expres
sion level of the gene coding for choline acetyltransferase (ChAT) was
evaluated using in situ hybridization in the caudate nucleus, putamen
and ventral striatum. Quantitative analysis showed (i) a marked decre
ase in the number of ChAT mRNA-positive neurons in the ventral striatu
m, and (ii) significantly reduced ChAT mRNA expression in the survivin
g cholinergic neurons of the ventral striatum, whereas it was only sli
ghtly decreased in those of the dorsal striatum. Our data support the
hypothesis of a down-regulated expression of ChAT in striatal choliner
gic neurons, especially in those most vulnerable to the neurodegenerat
ive process. The subnormal ChAT mRNA content may be the consequence of
changes in the level of transcription of the ChAT gene, possibly in r
elation to sustained suffering still present at the late stages of thi
s disease. Furthermore, the involvement of the ventral striatum in Alz
heimer's disease may account for some of the behavioral and motor dysf
unctions often observed in patients with AD. (C) 1997 Elsevier Science
Ireland Ltd.